ECOMED Research: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ECOMED Research
Largest movements
- Cash -€8,579
down €8,579 (-98.4%), from €8,715 to €136
mainly Net result for the year (-€8,556) and Smaller working-capital items (-€24)
- Profit (loss) carried forward -€8,556
down €8,556, from €1,012 to -€7,543
- Gross operating margin -€13,831
down €13,831, from €5,871 to -€7,960
- Depreciation -€422
down €422 (-100%), from €422 to €0
- Financial charges +€151
up €151 (+336%), from €45 to €196
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €9,416 | €853 | -€8,563 | -90.9% |
| Current assets | 29/58 | €9,416 | €853 | -€8,563 | -90.9% |
| Amounts receivable within one year | 40/41 | €270 | €270 | = | 0.0% |
| Other amounts receivable | 41 | €270 | €270 | = | 0.0% |
| Cash at bank and in hand | 54/58 | €8,715 | €136 | -€8,579 | -98.4% |
| Deferred charges and accrued income | 490/1 | €431 | €447 | +€16 | +3.7% |
| Total equity and liabilities | 10/49 | €9,416 | €853 | -€8,563 | -90.9% |
| Equity | 10/15 | €3,692 | -€4,863 | -€8,556 | |
| Contributions | 10/11 | €344 | €344 | = | 0.0% |
| Reserves | 13 | €2,336 | €2,336 | = | 0.0% |
| Non-distributable reserves | 130/1 | €103 | €103 | = | 0.0% |
| Reserves not available under the articles | 1311 | €103 | €103 | = | 0.0% |
| Distributable reserves | 133 | €2,233 | €2,233 | = | 0.0% |
| Profit (loss) carried forward | 14 | €1,012 | -€7,543 | -€8,556 | |
| Amounts payable | 17/49 | €5,723 | €5,716 | -€8 | -0.1% |
| Amounts payable within one year | 42/48 | €5,723 | €5,716 | -€8 | -0.1% |
| Trade debts | 44 | €387 | €400 | +€12 | +3.2% |
| Suppliers | 440/4 | €387 | €400 | +€12 | +3.2% |
| Taxes, remuneration and social security | 45 | €71 | €71 | = | 0.0% |
| Taxes | 450/3 | €71 | €71 | = | 0.0% |
| Other amounts payable | 47/48 | €5,265 | €5,245 | -€20 | -0.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €422 | €0 | -€422 | -100% |
| Other operating charges | 640/8 | €387 | €400 | +€12 | +3.2% |
| Gross operating margin | 9900 | €5,871 | -€7,960 | -€13,831 | |
| Operating profit (loss) | 9901 | €5,062 | -€8,359 | -€13,421 | |
| Financial charges | 65/66B | €45 | €196 | +€151 | +336% |
| Recurring financial charges | 65 | €45 | €196 | +€151 | +336% |
| Profit (loss) for the period before taxes | 9903 | €5,017 | -€8,556 | -€13,572 | |
| Income taxes | 67/77 | €71 | €0 | -€71 | -100% |
| Profit (loss) for the period | 9904 | €4,946 | -€8,556 | -€13,502 | |
| Profit (loss) for the period to be appropriated | 9905 | €4,946 | -€8,556 | -€13,502 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 18 October 2026 via checked.be.